Overview Request Sample Pages Request Customization Download PDF
You are viewing: Europe Digital Pathology Market analysis
Part of: Digital Pathology Market (Global)

The Europe Digital Pathology Market was valued at $218.7 Million in 2026 and projected to reach to $376.8 Million by 2031, representing a compound annual growth rate of 11.5%. Europe's digital pathology market is poised for sustained expansion driven by increasing healthcare digitalization, rising demand for accurate diagnostics, and substantial investments in laboratory infrastructure.

Europe Digital Pathology Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Digital Pathology Market Trends and Insights

  • This expansion reflects Europe's strong healthcare infrastructure, regulatory support, and increasing adoption of AI-driven diagnostic solutions across pathology laboratories.
  • Europe leads in digital transformation initiatives, with countries investing heavily in modernizing diagnostic workflows and improving patient outcomes through advanced imaging technologies. The European market benefits from stringent quality standards, established reimbursement frameworks, and a collaborative ecosystem of healthcare providers, technology vendors, and research institutions.
  • Europe's commitment to precision medicine and digital health integration is driving demand for whole slide imaging systems, cloud-based pathology platforms, and AI-powered diagnostic tools.
  • The 11.5% compound annual growth rate through 2031 underscores Europe's position as a key growth region, supported by aging populations requiring advanced diagnostic capabilities and regulatory mandates for digital health adoption..

Key Market Statistics

  • CAGR (2026-2031) 11.5% CAGR
  • Market Size, 2026 ~USD 218.7 Million
  • Forecast, 2031 ~USD 376.8 Million
  • Geography Europe

Europe Digital Pathology Market Overview

Market Valuation & Growth :

Europe's digital pathology market is valued at $218.7 million in 2026 and is projected to reach $376.8 million by 2031, representing a robust 11.5% CAGR. This growth trajectory underscores the region's commitment to modernizing pathology infrastructure.

AI-Driven Diagnostic Adoption :

European pathology laboratories are increasingly integrating AI-driven diagnostic solutions, enhancing accuracy and efficiency in tissue analysis. This technological advancement is supported by strong regulatory frameworks and healthcare investment across the region.

Healthcare Infrastructure Leadership :

Europe's advanced healthcare infrastructure and digital transformation initiatives position it as a leader in adopting digital pathology solutions. Countries across the region are investing heavily in modernizing diagnostic capabilities and laboratory automation.

Regulatory Support & Standardization :

European regulatory bodies are actively supporting digital pathology adoption through standardized guidelines and compliance frameworks. This regulatory clarity accelerates market penetration and encourages vendor innovation across member states.

Europe Digital Pathology Market Dynamics

  • The region's mature healthcare systems and strong regulatory environment create favorable conditions for technology adoption.
  • Key European markets including Germany, UK, and France are leading the transition toward digital-first pathology workflows, with smaller nations following suit through collaborative healthcare initiatives and cross-border knowledge sharing. The forecast period through 2031 will witness accelerated growth as AI integration becomes standard practice, reimbursement models evolve, and interoperability standards mature.
  • European pathology providers are prioritizing efficiency gains and diagnostic accuracy, positioning digital solutions as essential investments.
  • Continued government support, coupled with rising laboratory workloads and workforce constraints, will drive sustained market expansion across the continent..

Related Ecosystem

Healthcare Analytics

Top Technologies
    Top Companies

      Healthcare It

      Top Technologies
        Top Companies

          Key Takeaways

          • Europe's digital pathology market will grow from $218.7M (2026) to $376.8M (2031), representing a 72.3% increase over the forecast period.
          • Europe's 11.5% CAGR reflects strong regulatory support, established reimbursement models, and high healthcare spending across the region.
          • Europe leads in AI integration and precision medicine adoption, driving demand for advanced diagnostic platforms and whole slide imaging systems.
          • Europe's aging population and digital health mandates create sustained demand for modernized pathology infrastructure through 2031.

          Digital Pathology Market Report Scope

          Report Metric Details
          Base Year 2026
          Fastest Growing Segment PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (End User)
          Forecast Period 2026–2031
          Growth Rate CAGR of 12.5% from 2026 to 2031
          Largest Segment ONCOLOGY (Therapeutic Area)
          Market Size Base Year (Billions) ~USD 1.59 (2026)
          Revenue Forecast (Billions) ~USD 2.86 (2031)
          Segments Covered Product, Type, Technology, Application, Therapeutic Area, End User

          Europe Digital Pathology Market Report Segmentation

          6 segment dimensions are covered across the global market.

          By Product

          • Hardware
          • Software
          • Storage Systems

          By Type

          • AI & Computational Pathology Software
          • Biomarker Discovery & Validation
          • Brightfield Scanners
          • Cloud Storage
          • Drug Discovery & Efficacy Studies
          • Enterprise Digital Pathology Solutions/Platforms
          • Fluorescence Scanners
          • Human Pathology
          • Hybrid Storage
          • Image Analysis Software
          • Image Management Software
          • On-Premise Storage
          • Other Pre-Clinical Research
          • Other Scanners
          • Peripherals & Accessories
          • Toxicology & Safety Assessment
          • Veterinary Pathology
          • Whole Slide Imaging Scanners
          • Workstations & Viewing Systems

          By Technology

          • AI-Enabled Digital Pathology
          • Conventional Digital Pathology

          By Application

          • Academic & Translational Research
          • Clinical Diagnostics
          • Clinical Trials
          • Education & Training
          • Other Applications
          • Pre-Clinical Research
          • Telepathology

          By Therapeutic Area

          • Gastrointestinal Disease
          • Hematology
          • Infectious Disease
          • Neurology
          • Oncology
          • Other Therapeutic Areas

          By End User

          • Academic & Research Institutes
          • Contract Research Organizations
          • Diagnostic & Reference Laboratories
          • Hospitals & Health Systems
          • Other End Users
          • Pharmaceutical & Biotechnology Companies
          • Veterinary Laboratories

          Target Audience

          • Digital Pathology Vendors : Vendors need Europe-specific market data to develop localized product strategies, identify key customer segments, and prioritize market entry or expansion efforts across high-growth European countries.
          • Healthcare IT Investors : Investors require detailed regional market analysis to evaluate investment opportunities in European digital pathology companies, assess market maturity, and identify acquisition targets with strong growth potential.
          • Pathology Laboratory Operators : Laboratory managers and operators need market insights to benchmark their digital transformation progress, identify best-in-class solutions, and understand competitive positioning within their regional markets.
          • Healthcare Consultants & Advisors : Consultants advising healthcare organizations need comprehensive Europe market data to develop digital pathology implementation strategies, assess vendor capabilities, and guide technology adoption roadmaps.
          • Medical Device Manufacturers : Manufacturers require regional market intelligence to align product portfolios with European healthcare needs, understand regulatory requirements, and identify partnership opportunities with pathology providers.

          Key Companies in the Europe Digital Pathology Market

          CompanyHQOwnershipStrongest segments
          NIKON CORPORATIONJapanPublic CompanyImaging Business (digital cameras and cinema cameras),Precision Equipment Business (FPD exposure equipment),Healthcare Business (life science solutions),
          PIXCELLDATAIsraelPrivate CompanyCore data/analytics platform subscriptions,Professional services & implementation,Value-added modules & advanced analytics,
          SUNQUEST INFORMATION SYSTEMSUnited StatesPrivate CompanyCore LIS (Sunquest Laboratory, Multi-Lab Networking, Collect),Pathology and Anatomic Pathology (PowerPath, CoPathPlus),Blood Bank and Transfusion Management,
          CERNER CORPORATIONUnited StatesPrivate CompanyCerner Millennium and core clinical/financial applications,HealtheIntent population health and data platform,CareAware and device connectivity solutions,
          ZENSAR TECHNOLOGIES LTDIndiaPublic CompanyDigital and Application Services,Cloud Infrastructure and Security,Experience, Brand, and Creative Services,
          DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing, single-use, cell culture, filtration),Life Sciences (genomics, mass spec, imaging, lab automation),Diagnostics (clinical instruments, consumables, software),
          KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health,
          SECTRA ABSwedenPublic CompanyImaging IT Solutions,Secure Communications,Business Innovation (orthopedics, education, precision diagnostics),
          HAMAMATSU PHOTONICS K.K.JapanPublic CompanyElectron Tube (incl. photomultiplier tubes and radiation/x-ray sensors),Opto-Semiconductor (photodiodes, APDs, SPADs, MPPC, UV/IR sensors),Imaging and Measurement Instruments (cameras, spectrometers, x-ray systems, software),
          QUANTERIX CORPORATIONUnited StatesPublic CompanyHD-X instrument and related assays/consumables,SR-X instrument and related assays/consumables,SP-X planar array platform and multiplex assays,
          FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics),Business Innovation (office, document solutions, graphic communications),Electronics (display, semiconductor materials, storage, industrial equipment),
          HOLOGIC, INC.United StatesPrivate CompanyDiagnostics (Aptima, Panther, ThinPrep, Rapid Fetal Fibronectin),Breast Health (3D mammography, biopsy, localization, treatment support),GYN Surgical (MyoSure, NovaSure, Fluent, Acessa, CoolSeal),
          AIFORIAFinlandPublic CompanyClinical AI suite (viewer + cancer diagnostics),Aiforia Create (AI model development platform),Services, customization, and other software,

          NIKON CORPORATION

          Nikon Corporation is a Japanese public company founded in 1917 with 19,928 employees, known for manufacturing imaging and optical products.

          PIXCELLDATA

          Pixcelldata is a private company founded in 2010 and based in Israel.

          SUNQUEST INFORMATION SYSTEMS

          Sunquest Information Systems is a private company founded in 1979 and based in the United States.

          CERNER CORPORATION

          Cerner Corporation is a private company founded in 1979 in the United States with 25,150 employees, specializing in healthcare information technology.

          ZENSAR TECHNOLOGIES LTD

          Zensar Technologies Ltd is an Indian public company founded in 1963 with 10,066 employees, providing IT services and solutions.

          DANAHER CORPORATION

          Danaher Corporation is a public company founded in 1969 in the United States with 59,000 employees, operating as a diversified conglomerate.

          KONINKLIJKE PHILIPS N.V.

          Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees, operating as a global diversified technology corporation.

          SECTRA AB

          Sectra AB is a Swedish public company founded in 1957 with 1,365 employees, specializing in medical imaging and cybersecurity solutions.

          HAMAMATSU PHOTONICS K.K.

          Hamamatsu Photonics K.K. is a Japanese public company founded in 1953 with 6,601 employees, manufacturing photonic products and systems.

          QUANTERIX CORPORATION

          Quanterix Corporation is a public company founded in 2007 in the United States with 450 employees, specializing in biotech instrumentation.

          FUJIFILM HOLDINGS CORPORATION

          Fujifilm Holdings Corporation is a Japanese public company founded in 1934 with 73,526 employees, operating across imaging, healthcare, and materials sectors.

          HOLOGIC, INC.

          Hologic, Inc. is a private company founded in 1985 in the United States with 7,070 employees, specializing in medical diagnostics and imaging.

          AIFORIA

          Aiforia is a Finnish public company founded in 2013 with 76 employees, specializing in artificial intelligence solutions.

          Europe vs. other regions

          HowEurope compares to the other 3 regional blocs covered in this market.

          North America
          ~USD 463.9 Million · 10.6% wtd CAGR ·
          Asia Pacific
          ~USD 273 Million · 12.7% wtd CAGR ·
          Latin America
          ~USD 57.1 Million · 9.9% wtd CAGR ·
          Middle East & Africa
          ~USD 34 Million · 9.4% wtd CAGR ·

          Countries within Europe - compare and drill down

          Country2025 size (native)
          GermanyUSD 231.1 Million
          UKUSD 204.4 Million
          FranceUSD 174.2 Million
          ItalyUSD 74.5 Million
          SpainUSD 44.6 Million
          SwedenUSD 32.2 Million
          Rest Of EuropeUSD 133.7 Million

          Country market size visualization

          Germany
          USD 231.1 Million
          UK
          USD 204.4 Million
          France
          USD 174.2 Million
          Italy
          USD 74.5 Million
          Spain
          USD 44.6 Million
          Sweden
          USD 32.2 Million
          Rest Of Europe
          USD 133.7 Million

          Reasons to Buy this Report

          • Regional Market Segmentation : Gain detailed insights into Europe's digital pathology market with country-level breakdowns including Germany, UK, France, Italy, Spain, and Sweden. Understand regional variations in adoption rates, regulatory environments, and growth opportunities.
          • Competitive Landscape Analysis : Identify leading vendors, emerging players, and market consolidation trends specific to European pathology providers. Benchmark your position against regional competitors and understand market share dynamics across key European markets.
          • Regulatory & Compliance Insights : Navigate Europe's complex regulatory framework with comprehensive guidance on CE marking, GDPR compliance, and country-specific healthcare regulations. Understand how regulatory support is accelerating digital pathology adoption across the region.
          • Investment & Growth Opportunities : Identify high-growth segments, underserved markets, and emerging opportunities within Europe's digital pathology ecosystem. Discover which European countries and healthcare segments offer the highest ROI potential through 2031.
          • Strategic Planning & Forecasting : Leverage Europe-specific market forecasts and trend analysis to inform product development, market entry strategies, and partnership decisions. Make data-driven decisions based on regional growth projections and market dynamics.

          Frequently asked questions

          What is the current size of Europe's digital pathology market in 2026?

          Europe's digital pathology market is valued at $218.7 million in 2026, with strong growth anticipated through 2031.

          What is the projected market size for Europe's digital pathology sector by 2031?

          Europe's digital pathology market is forecast to reach $376.8 million by 2031, driven by regulatory adoption and technological advancement.

          What is the CAGR for Europe's digital pathology market?

          Europe's digital pathology market is expected to grow at an 11.5% compound annual growth rate from 2026 to 2031.

          What factors are driving growth in Europe's digital pathology market?

          Europe's market growth is driven by regulatory mandates, aging populations, AI adoption, reimbursement support, and healthcare infrastructure modernization.

          How does Europe's digital pathology market compare to global trends?

          Europe's 11.5% CAGR slightly trails the global 12.5% rate, but Europe maintains leadership in regulatory compliance and precision medicine integration.

          RESEARCH METHODOLOGY

          This research study involved the extensive use of both primary and secondary sources. It involved the analysis of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

          Secondary Research

          This research study extensively utilized secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive and commercially focused study of the digital pathology market, encompassing technical aspects and market dynamics. It also facilitated the identification of key players, market classification, industry trends, geographical markets, and significant market-related developments. Additionally, a database of prominent industry leaders was compiled through secondary research.

          Primary Research

          In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the digital pathology market. Primary sources from the demand side included personnel from pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, and academic & research institutes.

          Digital Pathology Market Size, and Share

          *Others include sales managers, marketing managers, and product managers.

          Note: Tiers are defined based on a company’s total revenue as of 2025: Tier 1 = > USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

          To know about the assumptions considered for the study, download the pdf brochure

          Market Size Estimation

          The total size of the digital pathology market was determined through data triangulation using the two approaches described below. After completing each approach, a weighted average was calculated based on the level of assumptions used in each approach.

          Digital Pathology Market Top Down and Bottom Up Approach

          Data Triangulation

          The size of the digital pathology market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as follows: -

          • Revenues for individual companies were gathered from public sources and databases.
          • Shares of leading players in the digital pathology market were gathered from secondary sources to the extent available. In certain cases, shares of digital pathology businesses have been determined through a detailed analysis of various parameters, including product portfolios, market positioning, selling prices, and geographic reach & strength. 
          • Individual shares or revenue estimates were validated through interviews with experts.
          • The total revenue in the digital pathology market was determined by extrapolating the market share data of major companies.

          Market Definition

          Digital pathology is an image-based information environment for managing and interpreting information generated from digitized glass slides. The process involves converting glass slides to digital pathology slides using digital pathology scanning solutions. A digital image is then generated, enabling high-resolution slide viewing.

          Key Stakeholders

          • Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, Ambulatory Centers, and Outpatient Clinics)
          • Digital Pathology Organizations
          • Senior Management
          • Finance/Procurement Department
          • R&D Department
          • Healthcare Data Aggregators
          • Venture Capitalists
          • Government Agencies
          • Healthcare Startups, Consultants, and Regulators
          • Academic Medical Institutes

          Report Objectives

          • To define, describe, and forecast the digital pathology market based on product, type, technology, application, therapeutic area, end user, and region
          • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
          • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall digital pathology market
          • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
          • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa.
          • To profile the key players and analyze their market shares and core competencies2
          • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall digital pathology market
          • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

          Available customizations:

          With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

          Company Information

          • Detailed analysis and profiling of additional market players (up to 5)

          Geographic Analysis

          • Further breakdown of the Rest of Asia Pacific digital pathology market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
          • Further breakdown of the Rest of Europe digital pathology market into Russia, Austria, Finland, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries

           

          Get the Full Digital Pathology Market Report

          Full forecast, segment splits, and company analysis for all Digital Pathology Market.

          Download Sample Pages Buy Report

          METHODOLOGY

          Need a Tailored Report?

          Customize this report to your needs

          Get 10% FREE Customization

          Customize This Report
          Fact checked
          Cite this Research
          DMCA.com Protection Status